Unraveling pleiotropic effects of statins on plaque rupture

被引：68

作者：

Palinski, W ^{[1
]}

Napoli, C ^{[1
]}

机构：

[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA

来源：

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2002年 / 22卷 / 11期

关键词：

D O I：

10.1161/01.ATV.0000038754.39483.CD

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1745 / 1750

页数：6

共 78 条

[21]

Fukumoto Y, 2001, CIRCULATION, V103, P993

[22] SIMVASTATIN INHIBITS THE OXIDATION OF LOW-DENSITY LIPOPROTEINS BY ACTIVATED HUMAN MONOCYTE-DERIVED MACROPHAGES [J].

GIROUX, LM ;

DAVIGNON, J ;

NARUSZEWICZ, M .

BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1165 (03) :335-338

[23] 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture [J].

Guijarro, C ;

Blanco-Colio, LM ;

Ortego, M ;

Alonso, C ;

Ortiz, A ;

Plaza, JJ ;

Diaz, C ;

Hernandez, G ;

Egido, J .

CIRCULATION RESEARCH, 1998, 83 (05) :490-500

[24] Immune mechanisms in atherosclerosis [J].

Hansson, GK .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) :1876-1890

[25] Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells [J].

Hernández-Perera, O ;

Pérez-Sala, D ;

Navarro-Antolín, J ;

Sánchez-Pascuala, R ;

Hernández, G ;

Díaz, C ;

Lamas, S .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2711-2719

[26] Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells [J].

Hernández-Presa, MA ;

Martín-Ventura, JL ;

Ortego, M ;

Gómez-Hernández, A ;

Tuñón, J ;

Hernández-Vargas, P ;

Blanco-Colio, LM ;

Mas, S ;

Aparicio, C ;

Ortega, L ;

Vivanco, F ;

Gerique, JG ;

Díaz, C ;

Hernández, G ;

Egido, J .

ATHEROSCLEROSIS, 2002, 160 (01) :49-58

[27] Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide - An overview [J].

Ignarro, LJ ;

Napoli, C ;

Loscalzo, J .

CIRCULATION RESEARCH, 2002, 90 (01) :21-28

[28] Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect -: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells [J].

Inoue, I ;

Goto, S ;

Mizotani, K ;

Awata, T ;

Mastunaga, T ;

Kawai, S ;

Nakajima, T ;

Hokari, S ;

Komoda, T ;

Katayama, S .

LIFE SCIENCES, 2000, 67 (08) :863-876

[29] HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells [J].

Ito, T ;

Ikeda, U ;

Shimpo, M ;

Ohki, R ;

Takahashi, M ;

Yamamoto, K ;

Shimada, K .

CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (02) :121-126

[30] Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse [J].

Johnson, JL ;

Jackson, CL .

ATHEROSCLEROSIS, 2001, 154 (02) :399-406

← 1 2 3 4 5 6 7 8 →